In trading on Friday, shares of Vanda Pharmaceuticals Inc crossed below their 200 day moving average of $15.29, changing hands as low as $15.15 per share. Vanda Pharmaceuticals Inc shares are currently trading down about 1.9% on the day.

Investors in Vanda Pharmaceuticals Inc saw new options begin trading this week, for the February 2018 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VNDA options chain for the new February 2018 contracts and identified one put and one call contract of particular interest.

Investors in Vanda Pharmaceuticals Inc saw new options begin trading this week, for the January 2018 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VNDA options chain for the new January 2018 contracts and identified one put and one call contract of particular interest.

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

In trading on Thursday, shares of Vanda Pharmaceuticals Inc crossed below their 200 day moving average of $15.26, changing hands as low as $14.65 per share. Vanda Pharmaceuticals Inc shares are currently trading off about 5.5% on the day.

Investors in Vanda Pharmaceuticals Inc saw new options begin trading this week, for the November 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VNDA options chain for the new November 17th contracts and identified one put and one call contract of particular interest.

In trading on Tuesday, shares of Vanda Pharmaceuticals Inc crossed above their 200 day moving average of $15.01, changing hands as high as $15.30 per share. Vanda Pharmaceuticals Inc shares are currently trading up about 8.2% on the day.

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below.
If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener:
http://www.thestreet.com/k/qr/flat/stock-screener.html
Upgrades: ADGE, ANTX, HY, RTRX, VNDA
Downgrades: CELP, FORD, GRC, HMSY, LNCE, MET, NCI, OUT, PLPC, UBA
Initiations: ADAP, DGLT
Read on to get TheStreet Quant Ratings' detailed report:

Investors in Vanda Pharmaceuticals Inc saw new options begin trading this week, for the May 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VNDA options chain for the new May 19th contracts and identified one put and one call contract of particular interest.

In trading on Monday, shares of Vanda Pharmaceuticals Inc crossed below their 200 day moving average of $14.20, changing hands as low as $14.10 per share. Vanda Pharmaceuticals Inc shares are currently trading off about 1.4% on the day.

In trading on Thursday, shares of Vanda Pharmaceuticals Inc crossed below their 200 day moving average of $13.75, changing hands as low as $13.55 per share. Vanda Pharmaceuticals Inc shares are currently trading off about 1.1% on the day.

Investors in Vanda Pharmaceuticals Inc saw new options begin trading this week, for the April 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VNDA options chain for the new April 21st contracts and identified one put and one call contract of particular interest.